Insider Buying at Aclaris Signals Confidence in Pharma Growth & Market Momentum
Insider buying at Aclaris Therapeutics signals strong board confidence in its dermatology pipeline and 2027 revenue boost, offering a rare high‑growth biotech opportunity.
5 minutes to read


